Clinical Trial: Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Ischemic Stroke
Study Type: INTERVENTIONAL
Official Title: Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke: An Open-label, Blinded Endpoint, Randomized Controlled Trial
Brief Summary:
An open-label, blinded endpoint, randomized controlled trial that includes patients diagnosed with non-disabling, non-large vessel occlusion, acute minor stroke within 4.5 hours of onset.Eligible participants would be randomly assigned to the thrombolysis group (intravenous alteplase) and the dual antiplatelet group (oral aspirin plus clopidogrel).The primary outcome is the proportion of the excellent functional outcome (modified Rankin scale 0-1) at 90 days.
Read more